Skip to content

Use of Intravenous Ketamine for Treatment Resistant Bipolar and Unipolar Depression : Sharing 3 years of Experience from the Misericordia Community Hospital

2019 APA Scientific Conference

Please click "Next" if you did not attend this session
350%
The session met the stated learning objectives:
Strongly disagree
Disagree
Somewhat disagree
Neither agree or disagree
Somewhat agree
Agree
Strongly agree
Briefly review rationale for use of IV ketamine for Treatment Resistant Depression and Bipolar Depression;
Present the Misericordia Community Hospital's IV ketamine protocol and share practical experiences in program development and patient care; and
Discussion/Questions.
Please rate the following on a scale of 1 to 5
(1 - strongly disagree and 5 - strongly agree):
Strongly disagree
Disagree
Somewhat disagree
Neither agree or disagree
Somewhat agree
Agree
Strongly agree
The session was educationally relevant.
The presenter was educationally effective.
The session provided interactive opportunities.
The session provided opportunities to identify and/or reflect on what was learned and its potential impact on my practice
Please rate the following on a scale of 1 to 5
(1 - strongly disagree and 5 - strongly agree):
Strongly disagree
Disagree
Somewhat disagree
Neither agree or disagree
Somewhat agree
Agree
Strongly agree
The session and presenter did NOT have commercial or other inappropriate bias.
Please provide any other comments you would like to share: